Cytokine gene polymorphisms in hepatitis C virus-related oral lichen planus. 2007

Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
Department of Biomedical Sciences and Human Oncology, Oral Medicine Section, University of Turin, Turin, Italy. marco-carrozzo@ncl.ac.uk

Cytokine polymorphisms may influence both the risk of developing oral lichen planus (OLP) and the outcome of hepatitis C virus (HCV)-infected patients and OLP has been frequently associated with HCV infection. The aim of the present study was to analyse whether cytokine polymorphisms may influence the susceptibility to HCV-related OLP. Thirty-five patients with OLP and chronic HCV infection (OLP-HCV+ve) took part in the study. As controls, 44 patients with OLP but without HCV (OLP-HCV-ve) infection and 140 healthy donors were studied. Thirteen cytokine genes with 22 single nucleotide polymorphisms (SNP) were studied. IFN-gamma UTR 5644 genotype frequencies showed an increase in number of A/T heterozygote in OLP-HCV+ve patients compared with OLP-HCV-ve that approached the statistical significance [P = 0.03, P-corrected (PC) = 0.66]. Contrarily, in OLP-HCV+ve patients, the frequency of genotype -308 G/A of the TNF-alpha was decreased, whereas the genotype -308 G/G was increased compared with OLP-HCV-ve (P = 0.0005, PC = 0.011 and P = 0.0016, PC = 0.0352, respectively). OLP patients with and without HCV infection showed a different genetic cytokine background suggesting distinct pathogenetic mechanisms.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
December 2018, Archives of oral biology,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
February 2011, Hepatitis monthly,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
July 2005, Archives of dermatology,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
January 2002, Oral diseases,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
October 1994, The Journal of dermatology,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
December 1998, Journal of hepatology,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
January 1994, Archives of dermatology,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
January 2011, Nigerian journal of clinical practice,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
May 1998, The American journal of gastroenterology,
Marco Carrozzo, and Ennia Dametto, and Maria Edvige Fasano, and Paolo Arduino, and Giorgio Bertolusso, and Federica Uboldi de Capei, and Sabina Rendine, and Antonio Amoroso
January 2006, Evidence-based dentistry,
Copied contents to your clipboard!